KCL Infra Projects Reports Strong FY26 Growth Amid Auditor Concerns

Revenue from operations surged 242.45% to ₹58.80 crore, and net profit grew 219.23% to ₹1.66 crore for the year ended March 31, 2026.

Reader Takeaway: Strong financial growth driven by operations, yet auditor flags unverified loans and old receivables.

What just happened

KCL Infra Projects Ltd. announced its audited financial results for the fiscal year ended March 31, 2026. The company reported a substantial increase in revenue from operations, which grew to ₹58.80 crore from ₹17.17 crore in the previous fiscal year. Net profit also saw a significant rise, climbing to ₹1.66 crore from ₹0.52 crore a year earlier. Basic Earnings Per Share (EPS) improved from ₹0.03 to ₹0.10.

Why this matters

This strong financial performance indicates robust business expansion and improved profitability. The significant growth in revenue suggests successful project execution or increased demand for the company's services. The rise in net profit and EPS further demonstrates the company's enhanced earning capacity and efficiency. However, the unmodified audit opinion was accompanied by 'Emphasis of Matter' paragraphs that point to potential underlying risks.

The backstory

In the previous fiscal year (FY25), KCL Infra Projects had reported revenues of ₹17.17 crore and a net profit of ₹0.52 crore. The current fiscal year's results show a significant turnaround and acceleration in growth, more than tripling its revenue and more than doubling its profit on a percentage basis.

What changes now

Investors will be closely watching how the management addresses the concerns raised by the auditors. The company needs to provide clarity and documentation for the unverified loans and make progress in recovering the long-outstanding trade receivables. The modification of the lease arrangement with C3 Multi Speciality Hospital, involving a reduced rent but a significantly increased security deposit, also warrants attention regarding its impact on liquidity.

Risks to watch

Key risks highlighted by the auditors include ₹4.32 crore in loans lacking verification, ₹2.69 crore in trade receivables outstanding for over three years, and ₹0.50 crore in unpaid MSMED dues. The substantial increase in the lease security deposit to ₹11 crore could also pose a liquidity challenge.

Auditor Concerns and Watch Points

The statutory auditors, SCAN & Co., issued an unmodified opinion but drew attention to several areas:

• Unverified Loans: Loans totaling ₹4.32 crore lack supporting documentation.
• Trade Receivables: ₹2.69 crore in receivables are overdue beyond three years.
• MSMED Dues: ₹0.50 crore is outstanding to micro and small enterprises for one to three years.
• Lease Modification: A significant change in the lease arrangement with C3 Multi Speciality Hospital Ltd., effective January 1, 2026, involves a reduced monthly rent but a drastically increased security deposit of ₹11 crore.

Context metrics (time-bound)

For the year ended March 31, 2026:

• Revenue from Operations: ₹58.80 crore (+242.45% YoY)
• Net Profit: ₹1.66 crore (+219.23% YoY)
• Basic EPS: ₹0.10 (+233.33% YoY)

For the year ended March 31, 2025:

• Revenue from Operations: ₹17.17 crore
• Net Profit: ₹0.52 crore
• Basic EPS: ₹0.03

What to track next

Investors should monitor the company's subsequent filings for updates on the verification of loans, recovery of trade receivables, resolution of MSMED dues, and the company's cash flow management in light of the increased security deposit for the lease modification.